NetworkNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Adds National Leader to Scientific Advisory Board
Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company, recently named Dr. Steven Levin, M.D., to its scientific advisory board. An article further discussing the appointment reads, “‘Dr. Levin’s vast experience with novel therapies in the anesthesiology and pain-management field, as well as his strong research interest to improve clinical practice in pain management, will be valuable scientific additions to Endonovo,’ Alan Collier, CEO of Endonovo Therapeutics, said in a news release (http://nnw.fm/PeF8s). ‘As a leader in the field of pain management, Steven will contribute valuable knowledge and expertise as we move our programs forward.’ . . . Levin’s membership in professional…







